Skip to main content
NCBI home page
Gut logoLink to Gut
. 1995 Feb;36(2):220–230. doi: 10.1136/gut.36.2.220

Characterisation of the influence of anti-gastrin, anti-epidermal growth factor, anti-oestradiol, and anti-luteinising hormone releasing hormone antibodies on the proliferation of 27 cell lines from the gastrointestinal tract.

F Darro 1, I Camby 1, A Kruczynski 1, J L Pasteels 1, J Martinez 1, R Kiss 1
PMCID: PMC1382408  PMID: 7883221

Abstract

Numerous data from published reports prove that the proliferation of gastrointestinal tumour cell lines are under the control of many hormones or growth factors, or both. Most of these publications report the influence on a very small number of cell lines of one or two such factors only. This work deals with the in vitro characterisation of the influence of the anti-gastrin, the anti-epidermal growth factor (EGF), the anti-oestradiol (E2), and the anti-luteinising hormone releasing hormone (LHRH) antibodies on the proliferation of a large series of gastrointestinal cell lines. Cell proliferation was assessed by means of the colorimetric MTT assay on a series of 27 gastrointestinal cell lines obtained from the American Type Culture Collection (ATCC). Of the 27 cell lines, the anti-gastrin, the anti-EGF, the anti-E2, and the anti-LHRH neutralising antibodies considerably influenced the proliferation of 13, 25, 12, and 16. No gastrointestinal cell line was unresponsive to the four antibodies simultaneously. The anti-gastrin and anti-EGF antibody induced effects on the 27 gastrointestinal cell line proliferation were significantly correlated, as was also the case for the anti-E2 and anti-LHRH antibody induced effects. Of the anti-gastrin, the anti-EGF, the anti-E2, and the anti-LHRH antibodies, it was the anti-EGF one that had the greatest influence, both quantitatively and qualitatively, on gastrointestinal cell proliferation. The correlation of the effects of definite anti-hormone antibodies is suggestive of a common mechanism of action for the corresponding hormones and casts some doubt on the efficiency of anti-hormone monotherapy.

Full text

PDF
220

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barranco S. C., Townsend C. M., Jr, Casartelli C., Macik B. G., Burger N. L., Boerwinkle W. R., Gourley W. K. Establishment and characterization of an in vitro model system for human adenocarcinoma of the stomach. Cancer Res. 1983 Apr;43(4):1703–1709. [PubMed] [Google Scholar]
  2. Bhat N. R., Hauser K. F., Kindy M. S. Cell proliferation and protooncogene induction in oligodendroglial progenitors. J Neurosci Res. 1992 Jul;32(3):340–349. doi: 10.1002/jnr.490320306. [DOI] [PubMed] [Google Scholar]
  3. Brattain M. G., Fine W. D., Khaled F. M., Thompson J., Brattain D. E. Heterogeneity of malignant cells from a human colonic carcinoma. Cancer Res. 1981 May;41(5):1751–1756. [PubMed] [Google Scholar]
  4. Brown J., Gallagher N. D. A specific gastrin receptor site in the rat stomach. Biochim Biophys Acta. 1978 Jan 3;538(1):42–49. doi: 10.1016/0304-4165(78)90250-7. [DOI] [PubMed] [Google Scholar]
  5. Carmichael J., DeGraff W. G., Gazdar A. F., Minna J. D., Mitchell J. B. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res. 1987 Feb 15;47(4):936–942. [PubMed] [Google Scholar]
  6. Coffey R. J., Jr, Goustin A. S., Soderquist A. M., Shipley G. D., Wolfshohl J., Carpenter G., Moses H. L. Transforming growth factor alpha and beta expression in human colon cancer lines: implications for an autocrine model. Cancer Res. 1987 Sep 1;47(17):4590–4594. [PubMed] [Google Scholar]
  7. Culouscou J. M., Remacle-Bonnet M., Garrouste F., Marvaldi J., Pommier G. Simultaneous production of IGF-I and EGF competing growth factors by HT-29 human colon cancer line. Int J Cancer. 1987 Nov 15;40(5):646–652. doi: 10.1002/ijc.2910400513. [DOI] [PubMed] [Google Scholar]
  8. Darro F., Kruczynski A., Etievant C., Martinez J., Pasteels J. L., Kiss R. Characterization of the differentiation of human colorectal cancer cell lines by means of Voronoi diagrams. Cytometry. 1993 Oct;14(7):783–792. doi: 10.1002/cyto.990140711. [DOI] [PubMed] [Google Scholar]
  9. Dexter D. L., Barbosa J. A., Calabresi P. N,N-dimethylformamide-induced alteration of cell culture characteristics and loss of tumorigenicity in cultured human colon carcinoma cells. Cancer Res. 1979 Mar;39(3):1020–1025. [PubMed] [Google Scholar]
  10. Fogh J., Fogh J. M., Orfeo T. One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice. J Natl Cancer Inst. 1977 Jul;59(1):221–226. doi: 10.1093/jnci/59.1.221. [DOI] [PubMed] [Google Scholar]
  11. Fogh J., Wright W. C., Loveless J. D. Absence of HeLa cell contamination in 169 cell lines derived from human tumors. J Natl Cancer Inst. 1977 Feb;58(2):209–214. doi: 10.1093/jnci/58.2.209. [DOI] [PubMed] [Google Scholar]
  12. Franks L. M., Hemmings V. J. A cell line from an induced carcinoma of mouse rectum. J Pathol. 1978 Jan;124(1):35–38. doi: 10.1002/path.1711240108. [DOI] [PubMed] [Google Scholar]
  13. Frucht H., Gazdar A. F., Park J. A., Oie H., Jensen R. T. Characterization of functional receptors for gastrointestinal hormones on human colon cancer cells. Cancer Res. 1992 Mar 1;52(5):1114–1122. [PubMed] [Google Scholar]
  14. Harrison J. D., Watson S., Morris D. L. The effect of sex hormones and tamoxifen on the growth of human gastric and colorectal cancer cell lines. Cancer. 1989 Jun 1;63(11):2148–2151. doi: 10.1002/1097-0142(19890601)63:11<2148::aid-cncr2820631113>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
  15. Hoosein N. M., Kiener P. A., Curry R. C., Brattain M. G. Evidence for autocrine growth stimulation of cultured colon tumor cells by a gastrin/cholecystokinin-like peptide. Exp Cell Res. 1990 Jan;186(1):15–21. doi: 10.1016/0014-4827(90)90204-n. [DOI] [PubMed] [Google Scholar]
  16. Huschtscha L., Rozengurt E., Bodmer W. F. Growth factor requirements of human colorectal tumour cells: relations to cellular differentiation. Eur J Cancer. 1991;27(12):1680–1684. doi: 10.1016/0277-5379(91)90445-j. [DOI] [PubMed] [Google Scholar]
  17. Kiss R., Salmon I., Pauwels O., Gras S., Danguy A., Etievant C., Pasteels J. L., Martinez J. In vitro influence of gastrin, oestradiol and gonadotropin-releasing hormone on HCT-15 and LoVo human colorectal neoplastic cell proliferation. Eur J Cancer. 1991;27(10):1268–1274. doi: 10.1016/0277-5379(91)90095-u. [DOI] [PubMed] [Google Scholar]
  18. Kiss R., de Launoit Y., Wouters W., Deslypere J. P., Lescrainier J. P., Paridaens R., Vokaer A., Decoster R., Pasteels J. L. Inhibitory action of androstenedione on the proliferation and cell cycle kinetics of aromatase-free MXT and MCF-7 mammary tumour cell lines. Eur J Cancer Clin Oncol. 1989 May;25(5):837–843. doi: 10.1016/0277-5379(89)90129-6. [DOI] [PubMed] [Google Scholar]
  19. Koenders P. G., Peters W. H., Wobbes T., Beex L. V., Nagengast F. M., Benraad T. J. Epidermal growth factor receptor levels are lower in carcinomatous than in normal colorectal tissue. Br J Cancer. 1992 Feb;65(2):189–192. doi: 10.1038/bjc.1992.39. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Lahm H., Suardet L., Laurent P. L., Fischer J. R., Ceyhan A., Givel J. C., Odartchenko N. Growth regulation and co-stimulation of human colorectal cancer cell lines by insulin-like growth factor I, II and transforming growth factor alpha. Br J Cancer. 1992 Mar;65(3):341–346. doi: 10.1038/bjc.1992.69. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Leibovitz A., Stinson J. C., McCombs W. B., 3rd, McCoy C. E., Mazur K. C., Mabry N. D. Classification of human colorectal adenocarcinoma cell lines. Cancer Res. 1976 Dec;36(12):4562–4569. [PubMed] [Google Scholar]
  22. Meggouh F., Lointier P., Pezet D., Saez S. Status of sex steroid hormone receptors in large bowel cancer. Cancer. 1991 Apr 1;67(7):1964–1970. doi: 10.1002/1097-0142(19910401)67:7<1964::aid-cncr2820670724>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
  23. Morris D. L., Watson S. A., Durrant L. G., Harrison J. D. Hormonal control of gastric and colorectal cancer in man. Gut. 1989 Apr;30(4):425–429. doi: 10.1136/gut.30.4.425. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983 Dec 16;65(1-2):55–63. doi: 10.1016/0022-1759(83)90303-4. [DOI] [PubMed] [Google Scholar]
  25. Murakami H., Masui H. Hormonal control of human colon carcinoma cell growth in serum-free medium. Proc Natl Acad Sci U S A. 1980 Jun;77(6):3464–3468. doi: 10.1073/pnas.77.6.3464. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Murakami H., Masui H. Hormonal control of human colon carcinoma cell growth in serum-free medium. Proc Natl Acad Sci U S A. 1980 Jun;77(6):3464–3468. doi: 10.1073/pnas.77.6.3464. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Murthy U., Anzano M. A., Greig R. G. Expression of TGF-alpha/EGF and TGF-beta receptors in human colon carcinoma cell lines. Int J Cancer. 1989 Jul 15;44(1):110–115. doi: 10.1002/ijc.2910440120. [DOI] [PubMed] [Google Scholar]
  28. Nelson-Rees W. A., Kniazeff A. J., Darby N. B., Jr Debut and accumulation of centric fusion products: an index to age of certain cell lines. Cytogenetics. 1967;6(6):436–450. doi: 10.1159/000129961. [DOI] [PubMed] [Google Scholar]
  29. New B. A., Yeoman L. C. Identification of basic fibroblast growth factor sensitivity and receptor and ligand expression in human colon tumor cell lines. J Cell Physiol. 1992 Feb;150(2):320–326. doi: 10.1002/jcp.1041500215. [DOI] [PubMed] [Google Scholar]
  30. O'Donnell R. W., Cockerell G. L. Establishment and biological properties of a guinea pig colonic adenocarcinoma cell line induced by N-methyl-N-nitrosourea. Cancer Res. 1981 Jun;41(6):2372–2377. [PubMed] [Google Scholar]
  31. Park J. G., Oie H. K., Sugarbaker P. H., Henslee J. G., Chen T. R., Johnson B. E., Gazdar A. Characteristics of cell lines established from human colorectal carcinoma. Cancer Res. 1987 Dec 15;47(24 Pt 1):6710–6718. [PubMed] [Google Scholar]
  32. Pauwels O., Kiss R. Digital morphonuclear analyses of sensitive versus resistant neoplastic cells to vinca-alkaloid, alkylating, and intercalating drugs. Cytometry. 1991;12(5):388–397. doi: 10.1002/cyto.990120503. [DOI] [PubMed] [Google Scholar]
  33. Petricciani J. C., Wallace R. E., McCoy D. W. A comparison of three in vivo assays for cell tumorigenicity. Cancer Res. 1974 Jan;34(1):105–108. [PubMed] [Google Scholar]
  34. Quinn L. A., Moore G. E., Morgan R. T., Woods L. K. Cell lines from human colon carcinoma with unusual cell products, double minutes, and homogeneously staining regions. Cancer Res. 1979 Dec;39(12):4914–4924. [PubMed] [Google Scholar]
  35. Rubin N. H., Singh P., Alinder G., Greeley G. H., Jr, Rayford P. L., Rietveld W. J., Thompson J. C. Circadian rhythms in gastrin receptors in rat fundic stomach. Dig Dis Sci. 1988 Aug;33(8):931–937. doi: 10.1007/BF01535987. [DOI] [PubMed] [Google Scholar]
  36. Rubinstein L. V., Shoemaker R. H., Paull K. D., Simon R. M., Tosini S., Skehan P., Scudiero D. A., Monks A., Boyd M. R. Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines. J Natl Cancer Inst. 1990 Jul 4;82(13):1113–1118. doi: 10.1093/jnci/82.13.1113. [DOI] [PubMed] [Google Scholar]
  37. Rutzky L. P., Giovanella B. C., Tom B. H., Kaye C. I., Noguchi P. D., Kahan B. D. Characterization of a human colonic adenocarcinoma cell line, LS123. In Vitro. 1983 Feb;19(2):99–107. doi: 10.1007/BF02621892. [DOI] [PubMed] [Google Scholar]
  38. Semple T. U., Quinn L. A., Woods L. K., Moore G. E. Tumor and lymphoid cell lines from a patient with carcinoma of the colon for a cytotoxicity model. Cancer Res. 1978 May;38(5):1345–1355. [PubMed] [Google Scholar]
  39. Singh P., Walker J. P., Townsend C. M., Jr, Thompson J. C. Role of gastrin and gastrin receptors on the growth of a transplantable mouse colon carcinoma (MC-26) in BALB/c mice. Cancer Res. 1986 Apr;46(4 Pt 1):1612–1616. [PubMed] [Google Scholar]
  40. Skehan P., Storeng R., Scudiero D., Monks A., McMahon J., Vistica D., Warren J. T., Bokesch H., Kenney S., Boyd M. R. New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst. 1990 Jul 4;82(13):1107–1112. doi: 10.1093/jnci/82.13.1107. [DOI] [PubMed] [Google Scholar]
  41. Speir G. R., Takeuchi K., Peitsch W., Johnson L. R. Mucosal gastrin receptor. VII. Up- and downregulation. Am J Physiol. 1982 Mar;242(3):G243–G249. doi: 10.1152/ajpgi.1982.242.3.G243. [DOI] [PubMed] [Google Scholar]
  42. Stevens R. H., Brooks G. P., Osborne J. W., Englund C. W., White D. W. Lymphocyte cytotoxicity in X-irradiation-induced adenocarcinoma of the rat small bowel. I. Measurement of target cell destruction by release of radioiodinated membrane proteins: brief communication. J Natl Cancer Inst. 1977 Oct;59(4):1315–1319. doi: 10.1093/jnci/59.4.1315. [DOI] [PubMed] [Google Scholar]
  43. Takeuchi K., Speir G. R., Johnson L. R. Mucosal gastrin receptor. I. Assay standardization and fulfillment of receptor criteria. Am J Physiol. 1979 Sep;237(3):E284–E294. doi: 10.1152/ajpendo.1979.237.3.E284. [DOI] [PubMed] [Google Scholar]
  44. Tanaka S., Imanishi K., Yoshihara M., Haruma K., Sumii K., Kajiyama G., Akamatsu S. Immunoreactive transforming growth factor alpha is commonly present in colorectal neoplasia. Am J Pathol. 1991 Jul;139(1):123–129. [PMC free article] [PubMed] [Google Scholar]
  45. Tom B. H., Rutzky L. P., Jakstys M. M., Oyasu R., Kaye C. I., Kahan B. D. Human colonic adenocarcinoma cells. I. Establishment and description of a new line. In Vitro. 1976 Mar;12(3):180–191. doi: 10.1007/BF02796440. [DOI] [PubMed] [Google Scholar]
  46. Tompkins W. A., Watrach A. M., Schmale J. D., Schultz R. M., Harris J. A. Cultural and antigenic properties of newly established cell strains derived from adenocarcinomas of the human colon and rectum. J Natl Cancer Inst. 1974 Apr;52(4):1101–1110. doi: 10.1093/jnci/52.4.1101. [DOI] [PubMed] [Google Scholar]
  47. Tricoli J. V., Rall L. B., Karakousis C. P., Herrera L., Petrelli N. J., Bell G. I., Shows T. B. Enhanced levels of insulin-like growth factor messenger RNA in human colon carcinomas and liposarcomas. Cancer Res. 1986 Dec;46(12 Pt 1):6169–6173. [PubMed] [Google Scholar]
  48. Vistica D. T., Skehan P., Scudiero D., Monks A., Pittman A., Boyd M. R. Tetrazolium-based assays for cellular viability: a critical examination of selected parameters affecting formazan production. Cancer Res. 1991 May 15;51(10):2515–2520. [PubMed] [Google Scholar]
  49. Watson S. A., Durrant L. G., Wencyk P. M., Watson A. L., Morris D. L. Intracellular gastrin in human gastrointestinal tumor cells. J Natl Cancer Inst. 1991 Jun 19;83(12):866–871. doi: 10.1093/jnci/83.12.866. [DOI] [PubMed] [Google Scholar]
  50. Watson S., Durrant L., Elston P., Morris D. Inhibitory effects of the gastrin receptor antagonist (L-365,260) on gastrointestinal tumor cells. Cancer. 1991 Sep 15;68(6):1255–1260. doi: 10.1002/1097-0142(19910915)68:6<1255::aid-cncr2820680613>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  51. Watson S., Durrant L., Morris D. Gastrin: growth enhancing effects on human gastric and colonic tumour cells. Br J Cancer. 1989 Apr;59(4):554–558. doi: 10.1038/bjc.1989.112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Weinstock J., Baldwin G. S. Binding of gastrin(17) to human gastric carcinoma cell lines. Cancer Res. 1988 Feb 15;48(4):932–937. [PubMed] [Google Scholar]
  53. Winsett O. E., Townsend C. M., Jr, Glass E. J., Thompson J. C. Gastrin stimulates growth of colon cancer. Surgery. 1986 Mar;99(3):302–307. [PubMed] [Google Scholar]
  54. Yasui W., Sumiyoshi H., Hata J., Kameda T., Ochiai A., Ito H., Tahara E. Expression of epidermal growth factor receptor in human gastric and colonic carcinomas. Cancer Res. 1988 Jan 1;48(1):137–141. [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES